RUNX2 and neoplasm: Promoted bone morphogenic protein 2, induced osteogenic differentiation under NIR, alkaline phosphatase activity, increased expression of Col, RUNX2, BSP bone-related genes and C2C12 myoblast cells, osteosarcoma cell death, inhibited tumor growth.